Quick Takeaways
- Lai Wang has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $786,064,813.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Lai Wang
- Location
- Grand Cayman
- Summary
- The estimated net worth of Lai Wang is at least $786,064,813 dollars as of 10 Mar 2026. Lai Wang is the President, Global Head of R&D of BeOne Medicines Ltd. and owns shares of BeOne Medicines Ltd. (ONC) stock worth about $786.06M.
- Signature
- /s/ Qing Nian, as Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Lai Wang and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: BeOne Medicines Ltd. ($786,064,813).
- Past-year value change for that position: -$4,314,519.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Lai Wang
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ONC, BEIGF | BeOne Medicines Ltd. | President, Global Head of R&D | $786,064,813 | -$4,314,519 | -0.55% | 06 Mar 2026 |
Insider Transactions Reported by Lai Wang:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.